| Literature DB >> 35340782 |
M Pitchaimani1, A Saranya Devi1.
Abstract
The ultimate aim of the article is to predict COVID-19 virus inter-cellular behavioral dynamics using an infection model with a quarantine compartment. Internal viral dynamics and stability attributes are thoroughly investigated around stable equilibrium states to probe possible ways in reducing rapid spread by incorporating fractional-order components into epidemic systems. Furthermore, a fractional optimal problem was built and studied with three control measures to restrict the widespread of COVID-19 infections and exhibit perfect protection. It is found that by following 60 % of control strategies can eradicate the infectives. Furthermore, the time frame of sixteen months has been divided into four short periods to grasp the pandemic, as the pandemic's parameters change over time. Finally, using real data, we estimated the parameters of the model system and the expression of the basic reproduction number R 0 for the most affected countries, China, USA, UK, Italy, France, Germany, Spain, and Iran.Entities:
Year: 2022 PMID: 35340782 PMCID: PMC8934028 DOI: 10.1140/epjp/s13360-022-02556-3
Source DB: PubMed Journal: Eur Phys J Plus ISSN: 2190-5444 Impact factor: 3.911
Fig. 1Flowchart diagram for model (2)
Parameters description
| Parameters | Description | Values | Units |
|---|---|---|---|
| [ | [Assumed] | ||
| The recruitment rate | 2274 | day | |
| The transmission rate by infectives at exposed class | 0.00003 | day | |
| The transmission rate by infectives at asymptomatic phase | 0.000111 | day | |
| The transmission rate by infectives at symptomatic phase | 0.0001197 | day | |
| The rate at which the exposed become asymptomatic | 0.094 | day | |
| The rate at which the asymptomatic become symptomatic | 0.09 | day | |
| Rate at which the exposed individuals are diminished by quarantine | 0.0986 | day | |
| Recovery rate from asymptomatic individuals | 0.9999 | day | |
| Recovery rate from symptomatic individuals | 0.16 | day | |
| Recovery rate from quarantined individuals | 0.2553 | day | |
| Recovery rate from hospitalized individuals | 0.4449 | day | |
| Rate at which symptomatic infectives are hospitalized | 0.10001 | day | |
| Rate at which quarantined individuals are hospitalized | 0.4129 | day | |
| Diseases induced rate form symptomatic infectives | 0.002 | day | |
| Diseases induced rate form hospitalized individuals | 0.001 | day | |
| The natural death rate | 0.3349 | day |
Fig. 2These scatter plots representations for the basic reproduction number and eight sampled input parameters values are the outputs derived using a sample size of 1000 by the method of Latin hypercube sampling
PRCCs for and eight input parameters
| S. no. | Parameter | PRCCs |
|---|---|---|
| 1 | 0.0442 | |
| 2 | 0.1354 | |
| 3 | 0.1981 | |
| 4 | 0.1150 | |
| 5 | 0.1150 | |
| 6 | ||
| 7 | ||
| 8 |
Fig. 3The PRCCs between input parameters and output
Fig. 4Denotes graph trajectories of S(t), E(t), A(t), I(t), Q(t) and H(t) versus time t of system (2) for , where
Fig. 5Denotes graph trajectories of S(t), E(t), A(t), I(t), Q(t) and H(t) versus time t of system (2) for , where
Fig. 6Denotes graph trajectories of system (2) for different values of , where
Fig. 7Denotes graph trajectories of system (2) for different values of , where
Fig. 8The above figure has been plotted with same initial conditions and parameters used for Fig. 5 with , which denotes the variation of parameter among symptomatic phase I(t) of system (2), where
Fig. 9The above figure has been plotted with same initial conditions and parameters used for Fig. 5 with , which denotes the variation of parameter among symptomatic phase I(t) of system (2), where
Fig. 10The above figure has been plotted with same initial conditions and parameters used for Fig. 5 with , which denotes the variation of parameter among symptomatic phase I(t) of system (2), where
Fig. 11The above figure denotes the impact of control on infectives for strategy No.1: ()
Fig. 12The above figure denotes the impact of control on infectives for strategy No.2: ()
Fig. 13The above figure denotes the impact of control on infectives for strategy No.3: ()
Fig. 14The above figure denotes the impact of control on infectives for strategy No.4: ()
Estimated parameter values of the model (2) for the countries China, USA, UK, Italy, France, Germany, Spain, Iran for phase 1, phase 2, phase 3 and phase 4
| Parameters | China | USA | UK | Italy | France | Germany | Spain | Iran |
|---|---|---|---|---|---|---|---|---|
| 0.00004 | 0.00026 | 0.00029 | 0.00009 | 0.00009 | 0.00012 | 0.00001 | 0.00015 | |
| 0.00101 | 0.00026 | 0.03892 | 0.0069 | 0.00837 | 0.00616 | 0.00806 | 0.00537 | |
| 0.00359 | 0.00273 | 0.002 | 0.00125 | 0.00226 | 0.00133 | 0.00423 | 0.00853 | |
| 1.38805 | 0.11143 | 0.61477 | 0.14328 | 0.24014 | 0.06381 | 0.01139 | 1.05788 | |
| 0.00808 | 0.37684 | 0.1581 | 0.06478 | 0.03731 | 0.01397 | 0.04956 | 0.00008 | |
| 0.26933 | 0.1563 | 0.15992 | 0.33229 | 0.33307 | 0.3705 | 0.73241 | 0.285 | |
| 0.52123 | 0.51084 | 0.49615 | 0.49901 | 0.50428 | 0.50053 | 0.50254 | 0.00859 | |
| 0.02553 | 0.00209 | 0.00168 | 0.00277 | 0.00494 | 0.00281 | 0.00209 | 0.00909 | |
| 0.00012 | 0.00036 | 0.00002 | 0.00004 | 0.0006 | 0.00009 | 0.00009 | 0.001 | |
| 0.00935 | 0.00035 | 0.00971 | 0.01167 | 0.00044 | 0.01805 | 0.00379 | 0.01855 | |
| 0.00159 | 0.0038 | 0.00098 | 0.00173 | 0.01159 | 0.00517 | 0.00112 | 0.00891 | |
| 0.1935 | 0.21821 | 0.00698 | 0.19984 | 0.10599 | 0.19697 | 0.24783 | 0.24977 | |
| 0.00708 | 0.42354 | 0.09491 | 0.07572 | 1.09817 | 0.38457 | 0.28016 | 0.04624 | |
| 0.4085 | 0.10666 | 0.4861 | 0.32141 | 0.44031 | 1.09854 | 0.20582 | 0.00276 | |
| 0.49797 | 0.50591 | 0.5155 | 0.51799 | 0.47546 | 0.52017 | 0.50517 | 0.51668 | |
| 0.00253 | 0.00081 | 0.00453 | 0.004 | 0.01848 | 0.00617 | 0.00005 | 0.00971 | |
| 0.00027 | 0.57291 | 0.22401 | 0.38324 | 0.00011 | 0.00017 | 0.00011 | 0.00035 | |
| 0.00759 | 0.00297 | 0.00359 | 0.00010 | 0.00317 | 0.00405 | 0.00390 | 0.00297 | |
| 0.00745 | 0.00150 | 0.00171 | 0.00270 | 0.00021 | 0.00076 | 0.00140 | 0.00880 | |
| 0.83848 | 0.47551 | 0.21380 | 0.36216 | 0.16487 | 0.03739 | 0.05561 | 0.47057 | |
| 0.01161 | 0.09362 | 0.29435 | 0.01072 | 0.00388 | 0.06884 | 0.31240 | 0.00496 | |
| 0.20023 | 0.11127 | 0.15637 | 0.40755 | 0.40792 | 0.33231 | 0.15320 | 0.15613 | |
| 0.49091 | 0.50863 | 0.50450 | 0.51040 | 0.50795 | 0.50400 | 0.50283 | 0.50291 | |
| 0.00431 | 0.01081 | 0.00689 | 0.01005 | 0.00660 | 0.00427 | 0.00434 | 0.00109 | |
| 0.00012 | 0.00037 | 0.00029 | 0.00072 | 0.00015 | 0.00009 | 0.00038 | 0.00024 | |
| 0.00917 | 0.00032 | 0.0027 | 0.01917 | 0.00585 | 0.00735 | 0.00921 | 0.00711 | |
| 0.00213 | 0.00443 | 0.00478 | 0.0117 | 0.00387 | 0.00011 | 0.00878 | 0.00223 | |
| 0.03085 | 0.86723 | 0.10458 | 5.3965 | 0.37149 | 0.36012 | 0.65545 | 0.18798 | |
| 0.00739 | 0.00556 | 0.0804 | 0.00266 | 0.0613 | 0.03337 | 0.00581 | 0.0004 | |
| 0.66585 | 0.53597 | 0.20224 | 5.19249 | 0.45202 | 0.34285 | 0.33273 | 0.25036 | |
| 0.49506 | 0.50793 | 0.50417 | 0.56561 | 0.49765 | 0.50092 | 0.49241 | 0.49909 | |
| 0.0002 | 0.00569 | 0.00262 | 0.07002 | 0.00127 | 0.00532 | 0.00826 | 0.00086 | |
Initial population values used for data calibration of the model (2) for the countries China, USA, UK, Italy, France, Germany, Spain and Iran for phase 1, phase 2, phase 3 and phase 4
| Initial population | China | USA | UK | Italy | France | Germany | Spain | Iran |
|---|---|---|---|---|---|---|---|---|
| 90000 | 1113000 | 187500 | 209500 | 200000 | 169000 | 240000 | 98000 | |
| 88000 | 1112000 | 186500 | 209000 | 190000 | 166000 | 230000 | 98000 | |
| 86000 | 1111000 | 185500 | 208000 | 180000 | 165000 | 220000 | 97000 | |
| 84000 | 1110000 | 183500 | 207000 | 170000 | 164000 | 200000 | 96000 | |
| 82000 | 1109000 | 182500 | 206000 | 160000 | 163000 | 190000 | 94000 | |
| 80000 | 1108000 | 181500 | 205000 | 150000 | 162000 | 180000 | 93000 | |
| 92000 | 6100000 | 370000 | 300000 | 190000 | 276000 | 500000 | 410000 | |
| 91000 | 6090000 | 360000 | 290000 | 180000 | 266000 | 490000 | 400000 | |
| 90000 | 6080000 | 350000 | 280000 | 170000 | 256000 | 480000 | 390000 | |
| 89780 | 6070000 | 340000 | 270000 | 169367 | 246000 | 470973 | 376894 | |
| 89000 | 6060000 | 330000 | 260000 | 150000 | 236000 | 460000 | 360000 | |
| 88000 | 6050000 | 320000 | 250000 | 140000 | 226000 | 450000 | 350000 | |
| 99000 | 20700000 | 2900000 | 2357000 | 2997000 | 2132150 | 2230000 | 1534000 | |
| 98000 | 20600000 | 2800000 | 2446000 | 2840000 | 2093400 | 2130000 | 1430000 | |
| 97000 | 20500000 | 2700000 | 2525000 | 2743000 | 1966500 | 2030000 | 1320000 | |
| 96023 | 20400000 | 2600000 | 2129376 | 2637018 | 1762637 | 1930000 | 1231429 | |
| 95000 | 20300000 | 2500000 | 2000000 | 2540000 | 1656000 | 1830000 | 1120000 | |
| 94000 | 20200000 | 2400000 | 1945000 | 2430000 | 1554000 | 1730000 | 1100000 | |
| 130000 | 35520000 | 4700000 | 7110000 | 6100000 | 3700000 | 3800000 | 2815000 | |
| 120000 | 34560000 | 4600000 | 6220000 | 5920000 | 3600000 | 3700000 | 2702400 | |
| 110000 | 33540000 | 4500000 | 5330000 | 5820000 | 3500000 | 3600000 | 2622000 | |
| 102517 | 32463748 | 4434157 | 4035617 | 5703499 | 3423900 | 3524077 | 2516157 | |
| 90000 | 31510000 | 4300000 | 3240000 | 5630000 | 3323900 | 3424077 | 2316159 | |
| 80000 | 30520000 | 4200000 | 2205000 | 5540000 | 3200000 | 3324077 | 2216157 | |
Fig. 19Denote real data of COVID-19 infected cases for countries China, UK, Italy, France, Germany, Spain, Iran for phase 1, phase 2, phase 3 and phase 4
Fig. 20Denote real data of COVID-19 infected cases for USA for phase 1, phase 2, phase 3 and phase 4
Fig. 15Denote the COVID-19 infected cases at symptomatic phase I(t) of system (2) fitted to real data of eight countries for phase 1
Fig. 16Denote the COVID-19 infected cases at symptomatic phase I(t) of system (2) fitted to real data of eight countries for phase 2
Fig. 17Denote the COVID-19 infected cases at symptomatic phase I(t) of system (2) fitted to real data of eight countries for phase 3
Fig. 18Denote the COVID-19 infected cases at symptomatic phase I(t) of system (2) fitted to real data of eight countries for phase 4
Value of using estimated parameter values
| Phase no. | China | USA | UK | Italy | France | Germany | Spain | Iran |
|---|---|---|---|---|---|---|---|---|
| Phase 1 | 3.792 | 3.869 | 1.0065 | 6.7417 | 11.7359 | 3.6395 | 4.912 | 17.834 |
| Phase 2 | 10.653 | 6.204 | 5.564 | 13.8 | 6.234 | 5.564 | 6.1977 | 4.778 |
| Phase 3 | 2.49687 | 7.9916 | 5.3619 | 3.970 | 3.7441 | 2.6921 | 3.2020 | 9.9458 |
| Phase 4 | 2.1795 | 2.3160 | 5.4796 | 48.5951 | 10.3758 | 13.2520 | 25.1879 | 10.8987 |